You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
AstraZeneca
Merck
Colorcon
Johnson and Johnson

Last Updated: February 24, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Fluoropyrimidine


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Fluoropyrimidine?

Fluoropyrimidine is an investigational drug.

There have been 227 clinical trials for Fluoropyrimidine. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2016.

The most common disease conditions in clinical trials are Colorectal Neoplasms, Stomach Neoplasms, and Adenocarcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), Hoffmann-La Roche, and Eli Lilly and Company.

There are eighty-six US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Fluoropyrimidine
TitleSponsorPhase
A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel AdenocarcinomaCancer Research UKPhase 3
A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel AdenocarcinomaKom Op Tegen KankerPhase 3
A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel AdenocarcinomaBelgian Group of Digestive OncologyPhase 3

See all Fluoropyrimidine clinical trials

Clinical Trial Summary for Fluoropyrimidine

Top disease conditions for Fluoropyrimidine
Top clinical trial sponsors for Fluoropyrimidine

See all Fluoropyrimidine clinical trials

US Patents for Fluoropyrimidine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Fluoropyrimidine   Start Trial Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators JANSSEN PHARMACEUTICA NV (Beerse, BE)   Start Trial
Fluoropyrimidine   Start Trial Combination chemotherapy comprising a liposomal prodrug of mitomycin C Lipomedix Pharmaceuticals Ltd. (Jerusalem, IL) Shaare Zedek Scientific Ltd. (Jerusalem, IL)   Start Trial
Fluoropyrimidine   Start Trial Bioactive substance in a barbed suture Covidien LP (Mansfield, MA)   Start Trial
Fluoropyrimidine   Start Trial Combination therapy with an anti-hyaluronan agent and therapeutic agent Halozyme, Inc. (San Diego, CA)   Start Trial
Fluoropyrimidine   Start Trial Cell-specific internalizing RNA aptamers against human CCR5 and uses therefore City of Hope (Duarte, CA) The Scripps Research Institute (La Jolla, CA)   Start Trial
Fluoropyrimidine   Start Trial Non-aqueous electrolyte and lithium secondary battery comprising same LG Chem, Ltd. (KR)   Start Trial
Fluoropyrimidine   Start Trial Substituted reverse pyrimidine Bmi-1 inhibitors PTC THERAPEUTICS, INC. (South Plainfield, NJ)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Fluoropyrimidine

Drugname Country Document Number Estimated Expiration Related US Patent
Fluoropyrimidine Australia 2017217542 2036-02-10   Start Trial
Fluoropyrimidine Brazil 112018016329 2036-02-10   Start Trial
Fluoropyrimidine Canada 3014314 2036-02-10   Start Trial
Fluoropyrimidine China 109071488 2036-02-10   Start Trial
Fluoropyrimidine Eurasian Patent Organization 201891799 2036-02-10   Start Trial
Fluoropyrimidine European Patent Office 3414233 2036-02-10   Start Trial
Fluoropyrimidine Israel 261046 2036-02-10   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Baxter
Express Scripts
Merck
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.